{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihabvapt2sfapjpnzyaejnzzmkwzkdwfz63kl3x2qlhabrbdlrsoy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3ml775u2rgd32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic5xffezkwbmbptis3uv5kvuf676kwtqn6ejkcl27fazifgsynlmu"
    },
    "mimeType": "image/jpeg",
    "size": 179504
  },
  "path": "/news/2026-05-glyt2-blocker-relieves-chronic-neuropathic.html",
  "publishedAt": "2026-05-06T12:40:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along with collaborators from the University of Sydney and the University of Copenhagen, have developed an approach that offers a clearer path toward safer, non-addictive pain therapies.",
  "title": "New GlyT2 blocker relieves chronic neuropathic pain without major side effects"
}